Monika Masanam, MD (@drmonikamd) 's Twitter Profile
Monika Masanam, MD

@drmonikamd

Breast Surgical Oncology Fellow @HarvardMed @MGHSurgery @BrighamSurgery @DanaFarber

ID: 552255459

linkhttps://asj.amegroups.org/post/view/interviews-with-outstanding-authors-2023#monikakmasanam calendar_today12-04-2012 21:11:25

120 Tweet

365 Followers

266 Following

Shwetha Kochi, MD (@shwethakochi_) 's Twitter Profile Photo

Super excited to be at the San Antonio Breast Cancer Symposium this December! Couldn’t have made it here without my amazing mentors Monika Masanam, MD Jennifer Son Lucy M. De La Cruz MD and the rest of the Breast Surgery team at Georgetown Medstar! #SABCS23

Super excited to be at the San Antonio Breast Cancer Symposium this December! Couldn’t have made it here without my amazing mentors <a href="/DrMonikaMD/">Monika Masanam, MD</a> <a href="/jenniferdson/">Jennifer Son</a> <a href="/LucyMDeLaCruzMD/">Lucy M. De La Cruz MD</a> and the rest of the Breast Surgery team at Georgetown Medstar! #SABCS23
Georgetown-WHC General Surgery Residency (@guh_whcsurgres) 's Twitter Profile Photo

Our chief residents are future surgeon leaders! Dr. Monika Masanam (RAS-ACS Board of Governors Liaison) and Dr. Rachael Essig (RAS-ACS Secretary) met with American College of Surgeons CEO, Dr. Patricia Turner, at Clinical Congress. #ACSCC23 Monika Masanam, MD @PTurnerMD Rachael Essig, MD

Our chief residents are future surgeon leaders! Dr. Monika Masanam (<a href="/RASACS/">RAS-ACS</a> Board of Governors Liaison) and Dr. Rachael Essig (<a href="/RASACS/">RAS-ACS</a> Secretary) met with <a href="/AmCollSurgeons/">American College of Surgeons</a> CEO, Dr. Patricia Turner, at Clinical Congress. 

#ACSCC23 <a href="/DrMonikaMD/">Monika Masanam, MD</a> @PTurnerMD <a href="/RachaelEssig/">Rachael Essig, MD</a>
Society of Surgical Oncology (@socsurgonc) 's Twitter Profile Photo

Thank you to all of our Breast Track Faculty and Fellows for a great first two days of Fellows Institute 2024 focused on the Breast Specialty! #FI24

Thank you to all of our Breast Track Faculty and Fellows for a great first two days of Fellows Institute 2024 focused on the Breast Specialty! #FI24
Surgical Oncology Insight (@surgoncinsight) 's Twitter Profile Photo

The goal of this primer is to educate the future generation of surgeons and prepare trainees for their clinical breast surgical oncology rotation in the operating room and with patient care on the management of benign breast disease and breast cancer ow.ly/hmSo50V1yVP

Monika Masanam, MD (@drmonikamd) 's Twitter Profile Photo

Grateful for the opportunity to present our work evaluating the safety of breast conserving therapy (BCT) in patients with multiple ipsilateral breast cancer (MIBC) after neoadjuvant systemic therapy. Thank you to Olga Kantor MD, MS, FACS and mentors at Dana-Farber Brigham and Women’s Department of Surgery #SSO2025

Grateful for the opportunity to present our work evaluating the safety of breast conserving therapy (BCT) in patients with multiple ipsilateral breast cancer (MIBC) after neoadjuvant systemic therapy. Thank you to <a href="/OKantorMD/">Olga Kantor MD, MS, FACS</a> and mentors at <a href="/DanaFarber/">Dana-Farber</a> <a href="/BrighamSurgery/">Brigham and Women’s Department of Surgery</a> #SSO2025
Shicha Kumar, MD (@shichakumar) 's Twitter Profile Photo

Glad I stayed through the end of #SSO2025 ! Breast abstracts this morning were so good 👏 And these 2 sessions on integrating technology and navigating diversification were super informative 🙏Society of Surgical Oncology Peter Learn MD Haejin In Dr. Nimmi Kapoor Monika Masanam, MD Andrea Barrio @drmediget

Glad I stayed through the end of #SSO2025 !  Breast abstracts this morning were so good 👏 And these 2 sessions on integrating technology and navigating diversification were super informative 🙏<a href="/SocSurgOnc/">Society of Surgical Oncology</a> <a href="/PeterLearnMD/">Peter Learn MD</a> <a href="/HInMD/">Haejin In</a> <a href="/DrNimmiKapoor/">Dr. Nimmi Kapoor</a> <a href="/DrMonikaMD/">Monika Masanam, MD</a> <a href="/AndreaBarrio7/">Andrea Barrio</a> @drmediget
OncoDaily (@oncodaily) 's Twitter Profile Photo

Fantastic presentation by Monika Masanam on MIBC after NST at SSO2025 - Olga Kantor Olga Kantor MD, MS, FACS Monika Masanam, MD oncodaily.com/blog/monika-ma… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #SSO2025 #MIBC #BladderCancer

Fantastic presentation by Monika Masanam on MIBC after NST at SSO2025 - Olga Kantor
<a href="/OKantorMD/">Olga Kantor MD, MS, FACS</a> <a href="/DrMonikaMD/">Monika Masanam, MD</a>

oncodaily.com/blog/monika-ma…

#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #SSO2025 #MIBC #BladderCancer
Olga Kantor MD, MS, FACS (@okantormd) 's Twitter Profile Photo

Fantastic presentation on our surgeon led DCIS program by Monika Masanam, MD - ET uptake was similar when prescribing shifted from med onc to surg onc, with a lot of enthusiasm for low dose tamoxifen in recent years #ASBrS2025 ASBrS Tari King MD Dr. E Mittendorf Dana-Farber’s Breast Oncology Center

Fantastic presentation on our surgeon led DCIS program by <a href="/DrMonikaMD/">Monika Masanam, MD</a> - ET uptake was similar when prescribing shifted from med onc to surg onc, with a lot of enthusiasm for low dose tamoxifen in recent years  #ASBrS2025 <a href="/ASBrS/">ASBrS</a> <a href="/TariKingMD/">Tari King MD</a> <a href="/EMittendorfMD/">Dr. E Mittendorf</a> <a href="/DFCI_BreastOnc/">Dana-Farber’s Breast Oncology Center</a>
Dr. E Mittendorf (@emittendorfmd) 's Twitter Profile Photo

Fantastic presentation by friend and colleague Tari King MD on atypical lesions and LCIS. Excise (most) ADH and P-LCIS; observe FEA/ALH/classic LCIS. Cancer risk 1-2% per yr; chemo prevention works! Look forward to publication reflecting ASBrS recommendations. #ASBrS2025

Fantastic presentation by friend and colleague <a href="/TariKingMD/">Tari King MD</a> on atypical lesions and LCIS. Excise (most) ADH and P-LCIS; observe FEA/ALH/classic LCIS. Cancer risk 1-2% per yr; chemo prevention works! Look forward to publication reflecting ASBrS recommendations. #ASBrS2025